| Year |
Citation |
Score |
| 2015 |
Sack BK, Wang X, Sherman A, Rogers GL, Markusic DM. Immune responses to human factor IX in haemophilia B mice of different genetic backgrounds are distinct and modified by TLR4. Haemophilia : the Official Journal of the World Federation of Hemophilia. 21: 133-9. PMID 25417755 DOI: 10.1111/hae.12522 |
0.355 |
|
| 2014 |
Sack BK, Herzog RW, Terhorst C, Markusic DM. Development of Gene Transfer for Induction of Antigen-specific Tolerance. Molecular Therapy. Methods & Clinical Development. 1: 14013. PMID 25558460 DOI: 10.1038/Mtm.2014.13 |
0.538 |
|
| 2014 |
Keitany GJ, Sack B, Smithers H, Chen L, Jang IK, Sebastian L, Gupta M, Sather DN, Vignali M, Vaughan AM, Kappe SH, Wang R. Immunization of mice with live-attenuated late liver stage-arresting Plasmodium yoelii parasites generates protective antibody responses to preerythrocytic stages of malaria. Infection and Immunity. 82: 5143-53. PMID 25267837 DOI: 10.1128/Iai.02320-14 |
0.317 |
|
| 2012 |
Sack BK, Merchant S, Markusic DM, Nathwani AC, Davidoff AM, Byrne BJ, Herzog RW. Transient B cell depletion or improved transgene expression by codon optimization promote tolerance to factor VIII in gene therapy. Plos One. 7: e37671. PMID 22655063 DOI: 10.1371/Journal.Pone.0037671 |
0.626 |
|
| 2011 |
Moghimi B, Zolotukhin I, Sack BK, Herzog RW, Cao O. High Efficiency Ex Vivo Gene Transfer to Primary Murine B Cells Using Plasmid or Viral Vectors. Journal of Genetic Syndromes & Gene Therapy. 2. PMID 23565344 DOI: 10.4172/2157-7412.1000103 |
0.526 |
|
| 2011 |
Moghimi B, Sack BK, Nayak S, Markusic DM, Mah CS, Herzog RW. Induction of tolerance to factor VIII by transient co-administration with rapamycin. Journal of Thrombosis and Haemostasis : Jth. 9: 1524-33. PMID 21585650 DOI: 10.1111/J.1538-7836.2011.04351.X |
0.59 |
|
| 2011 |
Hoffman BE, Martino AT, Sack BK, Cao O, Liao G, Terhorst C, Herzog RW. Nonredundant roles of IL-10 and TGF-β in suppression of immune responses to hepatic AAV-factor IX gene transfer. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 1263-72. PMID 21386826 DOI: 10.1038/Mt.2011.33 |
0.546 |
|
| 2010 |
Jayandharan GR, Zhong L, Sack BK, Rivers AE, Li M, Li B, Herzog RW, Srivastava A. Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses. Human Gene Therapy. 21: 271-83. PMID 19788390 DOI: 10.1089/Hum.2009.100 |
0.52 |
|
| 2010 |
Sack B, Moghimi B, Byrne B, Herzog RW. Anti-CD20 to Control Antibody Formation Against FVIII In Gene and Protein Replacement Therapy Blood. 116: 711-711. DOI: 10.1182/Blood.V116.21.711.711 |
0.587 |
|
| 2010 |
Moghimi B, Sack B, Cao O, Herzog RW. Tolerance Induction to B Domain-Deleted and Full-Length F.VIII by Co-Administration with Rapamycin Blood. 116: 21-21. DOI: 10.1182/Blood.V116.21.21.21 |
0.604 |
|
| 2009 |
Sack BK, Herzog RW. Evading the immune response upon in vivo gene therapy with viral vectors. Current Opinion in Molecular Therapeutics. 11: 493-503. PMID 19806497 |
0.522 |
|
| Show low-probability matches. |